An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Bicycle Therapeutics to Participate in Upcoming Investor Conferences
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Bicycle Therapeutics plc (NASDAQ: BCYC) announced its participation in several investor conferences throughout September 2021. Key events include the Goldman Sachs Eleventh Annual Biotech Symposium on September 7, a pre-recorded presentation at H.C. Wainwright's Global Investment Conference on September 13, the Morgan Stanley Global Healthcare Conference on September 14, and the Cantor Virtual Global Healthcare Conference on September 27. Live webcasts of these events will be available on Bicycle's website, with archived replays accessible for 30 days.
Positive
None.
Negative
None.
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--
Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced that management will participate in the following investor conferences in September:
Goldman Sachs Eleventh Annual Biotech Symposium on Tuesday, September 7, 2021
H.C. Wainwright 23rd Annual Global Investment Conference on Monday, September 13, 2021; pre-recorded presentation available on demand at 7:00 a.m. ET
Morgan Stanley 19th Annual Global Healthcare Conference on Tuesday, September 14, 2021
Cantor Virtual Global Healthcare Conference on Monday, September 27, 2021; fireside chat at 11:20 a.m. ET
A live webcast of the fireside chats and replay of the pre-recorded presentation will be accessible in the Investors & Media section of Bicycle’s website at www.bicycletherapeutics.com. Archived replays of the webcasts will be available for 30 days following the pre-recorded presentation and fireside chat dates.
About Bicycle Therapeutics
Bicycle Therapeutics (NASDAQ: BCYC) is a clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycles, for diseases that are underserved by existing therapeutics. Bicycles are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry. This constraint facilitates target binding with high affinity and selectivity, making Bicycles attractive candidates for drug development. Bicycle is evaluating BT5528, a second-generation Bicycle Toxin Conjugate (BTC™) targeting EphA2, and BT8009, a second-generation BTC™ targeting Nectin-4, a well-validated tumor antigen, in company-sponsored Phase I/II trials. In addition, BT1718, a BTC™ that targets MT1-MMP, is being investigated in an ongoing Phase I/IIa clinical trial sponsored by the Centre for Drug Development of Cancer Research UK. Bicycle is headquartered in Cambridge, UK, with many key functions and members of its leadership team located in Lexington, MA. For more information, visit bicycletherapeutics.com.
What investor conferences is Bicycle Therapeutics attending in September 2021?
Bicycle Therapeutics will attend the Goldman Sachs Eleventh Annual Biotech Symposium on September 7, H.C. Wainwright's Global Investment Conference on September 13, the Morgan Stanley Global Healthcare Conference on September 14, and the Cantor Virtual Global Healthcare Conference on September 27, 2021.
Where can I watch the Bicycle Therapeutics presentations from September 2021?
You can watch the live webcasts and archived presentations from the investor conferences on Bicycle Therapeutics' Investors & Media section of their website.
What is the stock symbol for Bicycle Therapeutics?
The stock symbol for Bicycle Therapeutics is BCYC, and it is listed on NASDAQ.
What is Bicycle Therapeutics known for?
Bicycle Therapeutics is known for developing a new class of therapeutics based on its proprietary bicyclic peptide technology, targeting diseases that are underserved by existing treatments.
What upcoming events are scheduled for Bicycle Therapeutics in September?
Bicycle Therapeutics has several scheduled events in September including investor conferences and presentations, specifically on the 7th, 13th, 14th, and 27th.
Bicycle Therapeutics plc American Depositary Shares
